Adherex Announces ASCO Abstract of ADH-1 in Melanoma (Marketwire)

yahoo.com     May 19, 2008            

RESEARCH TRIANGLE PARK, NORTH CAROLINA--(MARKET WIRE)--May 19, 2008 -- Adherex Technologies Inc. (AMEX: ), a biopharmaceutical company devoted to solving problems for patients with cancer, announced today the publication of an abstract on the phase I/II study of ADH-1 in combination with isolated... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies